What is the recommended dosing for Luvox (fluvoxamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Fluvoxamine (Luvox)

The recommended starting dose for fluvoxamine in adults is 50 mg once daily at bedtime, with titration in 50 mg increments every 4-7 days up to a maximum of 300 mg per day. 1

Adult Dosing Protocol

Initial Dosing and Titration

  • Starting dose: 50 mg once daily at bedtime
  • Titration: Increase by 50 mg increments every 4-7 days as tolerated
  • Maximum dose: 300 mg per day
  • Dosing strategy:
    • Doses >100 mg should be divided into two daily doses
    • If using divided doses, the larger dose should be given at bedtime 1

Special Populations

Elderly or Hepatically Impaired Patients

  • Lower starting doses and slower titration are recommended due to decreased clearance of fluvoxamine 1

Pregnant Women (Third Trimester)

  • Consider tapering fluvoxamine during the third trimester due to potential complications in neonates requiring prolonged hospitalization, respiratory support, and tube feeding 1

Pediatric Dosing

Children (8-11 years)

  • Starting dose: 25 mg once daily at bedtime
  • Titration: Increase in 25 mg increments every 4-7 days as tolerated
  • Maximum dose: 200 mg per day 1

Adolescents (12-17 years)

  • Starting dose: 25 mg once daily at bedtime
  • Titration: Increase in 25 mg increments every 4-7 days as tolerated
  • Maximum dose: 300 mg per day (same as adults) 1
  • Note: Therapeutic effect in female adolescents may be achieved with lower doses 1

Discontinuation Protocol

  • Gradual reduction rather than abrupt cessation is recommended
  • If intolerable symptoms occur during discontinuation:
    • Resume previously prescribed dose
    • Continue decreasing at a more gradual rate 1

Clinical Pearls and Caveats

Therapeutic Indications

  • FDA-approved for Obsessive-Compulsive Disorder (OCD)
  • In clinical trials for OCD, effective doses ranged from 100-300 mg/day 1
  • Has shown efficacy in anxiety disorders including social phobia, separation anxiety disorder, and generalized anxiety disorder 2, 3

Common Adverse Effects

  • Most common: Gastrointestinal disturbances and CNS effects 2, 3
  • Abdominal discomfort occurs more frequently with fluvoxamine than placebo 2
  • Most adverse events are mild to moderate in severity 4

Drug Interactions

  • Exercise caution when using fluvoxamine with alprazolam or triazolam 5
  • Fluvoxamine may prolong half-life of other drugs by inhibiting various cytochrome P450 isoenzymes 5

Monitoring

  • Regular assessment to determine need for continued treatment
  • Maintain patient on lowest effective dosage 1

Evidence Quality Considerations

While a case report has documented use of fluvoxamine at 600 mg daily with good tolerance in a treatment-resistant OCD patient 6, this exceeds the FDA-approved maximum dose of 300 mg daily and should not be routinely recommended without specialist consultation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.